PoS, agree POH is certainly improving its communication as they go.
Once they have finalised distribution for another large market, i.e. one of China, India or Korea, it would be good to get an estimate of what annual sales from all markets is expected. This is often done by other biotechs, and would give existing/potential holders some means to evaluate potential cash flow.
Continue to kick goals, and still look very cheap to me.
300 priceline stores stock poh, page-4
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.096K | 438.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 86702619 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 59480558 | 19 |
View Market Depth
| Last trade - 15.24pm 16/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |